Cleanspace Holdings Ltd - Asset Resilience Ratio
Cleanspace Holdings Ltd (CSX) has an Asset Resilience Ratio of 29.39% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Cleanspace Holdings Ltd to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how Cleanspace Holdings Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Cleanspace Holdings Ltd.
Liquid Assets Composition Over Time
This chart breaks down Cleanspace Holdings Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Cleanspace Holdings Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$7.91 Million | 29.39% |
| Total Liquid Assets | AU$7.91 Million | 29.39% |
Asset Resilience Insights
- Very High Liquidity: Cleanspace Holdings Ltd maintains exceptional liquid asset reserves at 29.39% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Cleanspace Holdings Ltd Industry Peers by Asset Resilience Ratio
Compare Cleanspace Holdings Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
|
Profound Medical Corp
TO:PRN |
Medical Devices | 67.66% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Epitomee Medical Ltd
TA:EPIT |
Medical Devices | 0.24% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
Annual Asset Resilience Ratio for Cleanspace Holdings Ltd (2016–2024)
The table below shows the annual Asset Resilience Ratio data for Cleanspace Holdings Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 28.85% | AU$7.95 Million ≈ $5.63 Million |
AU$27.57 Million ≈ $19.51 Million |
+1.92pp |
| 2023-12-31 | 26.93% | AU$7.02 Million ≈ $4.96 Million |
AU$26.05 Million ≈ $18.43 Million |
-4.27pp |
| 2022-12-31 | 31.21% | AU$9.04 Million ≈ $6.40 Million |
AU$28.98 Million ≈ $20.50 Million |
-10.71pp |
| 2021-12-31 | 41.92% | AU$16.08 Million ≈ $11.38 Million |
AU$38.36 Million ≈ $27.14 Million |
+10.30pp |
| 2020-12-31 | 31.62% | AU$16.03 Million ≈ $11.35 Million |
AU$50.72 Million ≈ $35.89 Million |
+24.43pp |
| 2019-12-31 | 7.18% | AU$3.58 Million ≈ $2.53 Million |
AU$49.80 Million ≈ $35.24 Million |
-19.39pp |
| 2018-12-31 | 26.57% | AU$2.03 Million ≈ $1.44 Million |
AU$7.66 Million ≈ $5.42 Million |
+18.85pp |
| 2017-12-31 | 7.72% | AU$629.10K ≈ $445.13K |
AU$8.14 Million ≈ $5.76 Million |
-16.97pp |
| 2016-12-31 | 24.70% | AU$1.28 Million ≈ $906.65K |
AU$5.19 Million ≈ $3.67 Million |
-- |
About Cleanspace Holdings Ltd
CleanSpace Holdings Limited designs, manufactures, and sells respirators and related products and services for people working in industrial and healthcare environments in the United Kingdom, rest of Europe, the Asia Pacific, North America, and internationally. The company offers CleanSpace HALO, which provides an elevated level of respiratory protection in healthcare environments; CleanSpace CST … Read more